Companies: 10,795·Total market cap: $144.5T
Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc.

INDPNASDAQHealthcare● Active
$2.10
$-1.56(-42.62%)
Market Cap$3677138
P/E Ratio—
52W High$19.908
52W Low$0.92
SEC Filings

Indaptus Therapeutics, Inc. (INDP) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001857044 · INDP · NASDAQ · as of Jun 9, 2026

Filing snapshot

316
Total Filings
8-K
Latest Form
2026-06-05
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001857044 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-17
Fiscal Year End
Mar 17, 2026
Accession No.
0001493152-26-010585
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001857044 · Accession 0001493152-26-010585

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-15
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-05Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-05
View
10-QQuarterly Report
10-Q
2026-05-15
View
8-KCurrent Report
8-K
2026-05-15
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-29
View
8-K/ACurrent Report (Amended)
8-K/A
2026-04-24
View
8-KCurrent Report
8-K
2026-04-23
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-04-20
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-04-06
View
8-KCurrent Report
8-K
2026-04-03
View
3Initial Statement of Beneficial Ownership
3
2026-04-02
View
3Initial Statement of Beneficial Ownership
3
2026-04-02
View
3Initial Statement of Beneficial Ownership
3
2026-04-02
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-03-30
View
8-KCurrent Report
8-K
2026-03-24
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-03-24
View
Showing 1–15 of 232 filingsForm 4 / 144 hidden· 316 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001857044  |  Exchange: NASDAQ · Healthcare

Indaptus Therapeutics, Inc. (NASDAQ: INDP) has submitted 316 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001857044, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Indaptus Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Indaptus Therapeutics, Inc. 10-K was filed on 2026-03-17 for fiscal year ending 2026. Historical INDP 10-K annual reports are available from 2021 through 2026.

Investors researching Indaptus Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
NKGN SEC Filings →SLRX SEC Filings →GTBP SEC Filings →REVB SEC Filings →AZTR SEC Filings →SLXN SEC Filings →ATXI SEC Filings →PTIX SEC Filings →
→ INDP Financials→ INDP Earnings→ INDP Insider Trades

Frequently Asked Questions

INDP SEC Filings · 8 questions

Indaptus Therapeutics, Inc. (INDP) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 316 filings and access original documents at no cost. Indaptus Therapeutics, Inc.'s CIK is 0001857044.

INDP SEC filingsIndaptus Therapeutics, Inc. SEC documentsfind INDP 10-K